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AbstrAct
Objective To develop a complex intervention for 
community pharmacy staff to promote uptake of smoking 
cessation services and to increase quit rates.
Design Following the Medical Research Council 
framework, we used a mixed-methods approach to 
develop, pilot and then refine the intervention.
Methods Phase I: We used information from qualitative 
studies in pharmacies, systematic literature reviews 
and the Capability, Opportunity, Motivation—Behaviour 
framework to inform design of the initial version of the 
intervention. Phase II: We then tested the acceptability 
of this intervention with smoking cessation advisers and 
assessed fidelity using actors who visited pharmacies 
posing as smokers, in a pilot study. Phase III: We reviewed 
the content and associated theory underpinning our 
intervention, taking account of the results of the earlier 
studies and a realist analysis of published literature. We 
then confirmed a logic model describing the intended 
operation of the intervention and used this model to refine 
the intervention and associated materials.
setting Eight community pharmacies in three inner east 
London boroughs.
Participants 12 Stop Smoking Advisers.
Intervention Two, 150 min, skills-based training sessions 
focused on communication and behaviour change skills 
with between session practice.
results The pilot study confirmed acceptability of the 
intervention and showed preliminary evidence of benefit; 
however, organisational barriers tended to limit effective 
operation. The pilot data and realist review pointed to 
additional use of Diffusion of Innovations Theory to seat 
the intervention in the wider organisational context.
conclusions We have developed and refined an 
intervention to promote smoking cessation services in 
community pharmacies, which we now plan to evaluate in 
a randomised controlled trial.
trial registration number UKCRN ID 18446, Pilot.
IntrODuctIOn
Recent years have seen increasing use of 
community pharmacies for health behaviour 
change interventions. This shift in phar-
macy practice in the UK is underpinned by 
Department of Health policy1 and reflected 
in the drive towards Healthy Living Pharma-
cies.2 Perhaps the best established of the new 
health promotion functions is smoking cessa-
tion, and community pharmacies now have 
a prominent place in delivery of National 
Health Service (NHS) Stop Smoking 
Services, commissioned through a new 
contractual framework.3While there is consid-
erable potential for community pharmacies 
to support people in quitting, translation into 
effective practice may be less than optimal, 
since 4-week quit rates are only 48% which is 
below the target 70%.4 5 An important barrier 
may be a lack of awareness about the public 
health services now offered by community 
pharmacies.6 Research also suggests that 
while pharmacy workers see a role for them-
selves in delivering interventions to change 
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Research
strengths and limitations of this study
 ► We used a detailed mixed-methods approach aligned 
with Medical Research Council recommendations 
to develop a theory-driven intervention to promote 
smoking cessation in community pharmacies.
 ► We used observational data, together with theories 
of behaviour change, to develop an initial version of 
the intervention which we piloted in pharmacies.
 ► We used standardised simulated client methods to 
evaluate intervention fidelity by assessing real-life 
pharmacy worker behaviour.
 ► Following piloting and feasibility testing, we refined 
the intervention using organisational theory to 
facilitate implementation.
 ► We developed a detailed programme theory, 
specified through a logic model, to operationalise 
the hypothesised mechanisms of change.
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health behaviours, their level of confidence is low,7 
possibly related to lack of training,8 and this may limit 
their effectiveness.
A number of studies have aimed to improve smoking 
cessation services in pharmacies through development of 
training sessions for pharmacists. These studies suggest 
some benefits including an increased level of smoking 
cessation counselling,9 10 higher quit rates,11 12 increased 
cost effectiveness13 and sustained positive effects on phar-
macist consulting behaviour.12 14 A Cochrane review also 
shows that pharmacists could increase smoking cessa-
tion rates by providing a counselling and record-keeping 
support programme for their customers.15
While previous interventions have shown benefits, these 
have not necessarily been translated into practice and 
their focus was primarily on the smoking cessation consul-
tation itself rather than engagement into the stop smoking 
service. We therefore established the Smoking Treatment 
Optimisation in Pharmacies (STOP) programme, which 
aims to increase self-efficacy and motivation of pharmacy 
workers, promoting engagement of smokers into the NHS 
stop smoking service and optimising delivery of consulta-
tions. We aim to develop client-centred communication 
and behaviour change skills, thus enabling workers to 
facilitate health behaviour change in service users more 
effectively. The STOP intervention does not replace 
training provided by the National Centre for Smoking 
Cessation Training (NCSCT), but builds on and rein-
forces many of the behaviour change techniques learnt.16
In developing the STOP intervention, we aimed to 
build on results of previous studies by making the theo-
retical basis for the intervention more explicit and by 
taking into account the wider organisational context in 
which the intervention is intended to operate. This paper 
reports (1) the process of developing the theory-based 
intervention; (2) evaluating acceptability to smoking 
cessation advisers and assessing fidelity in a pilot trial; 
and (3) refinement of the intervention.
PhAse I: InterventIOn DevelOPMent
Methods
We followed the Medical Research Council guidelines 
for development of complex interventions17 18 aiming to 
develop a programme theory with hypothesised mech-
anisms and predicates. We recognised that in order 
to change three distinct target behaviours of smokers, 
namely (1) engagement in stop smoking services, (2) 
retention in the stop smoking service and (3) sustained 
cessation, we needed to bring about fundamental change 
in pharmacy workers’ consulting behaviour.
We based our initial work on the Capability, Oppor-
tunity, Motivation—Behaviour (COM-B) model which 
is a behaviour change framework used to guide devel-
opment of behavioural interventions.19 20 In this model, 
behaviour is considered to be influenced by physical and 
psychological capacity to engage in an action, motivation 
towards the behaviour (including both conscious and 
habitual drivers) and by physical and social opportunity 
to perform the behaviour.20 We considered each of these 
elements in relation to the three target behaviours to 
develop appropriate intervention materials and to plan 
training sessions.
The intervention was also informed by findings from 
five areas of work each described in detail below including 
qualitative studies in local pharmacies (interviews and 
conversation analysis of audio recoded consultations), 
literature synthesis, realist review of smoking cessation 
interventions in community pharmacies, theoretical 
modelling and piloting in pharmacies. We also secured 
input from an expert professional advisory group 
comprising pharmacists (n=2), health psychologists 
(n=2), general practitioners (n=3), stop smoking experts 
(n=2) and trialists (n=2).
results
Synthesis of prior literature
Our initial review of the literature on behaviour change 
interventions in community pharmacy6 21 22 showed that 
such interventions could be successfully implemented 
and were most likely to be successful when supported 
by specific training. Further synthesis of the literature 
provided information on practicalities such as length of 
training, with shorter durations (2 hours) as effective, 
and potentially more acceptable, than longer training 
sessions.23
QuAlItAtIve stuDIes
Semistructured interviews with pharmacy workers about 
their experiences of the smoking cessation service 
delivery were conducted and analysed using a frame-
work approach17 based on the COM-B model.24 One 
key finding was that cessation advisers had preconceived 
ideas about which smokers were likely to join or to drop 
out of the service and made judgements about the client’s 
likelihood of quitting. These judgements then influenced 
the time advisers would spend encouraging a smoker to 
join the service. In part this behaviour resulted from lack 
of confidence in skills to engage and to motivate smokers, 
particularly those not actively asking for help. There was 
also a concern about potentially challenging interactions 
with some smokers, for example, smokers who particu-
larly enjoyed smoking or those who did not see any harm 
in continuing to smoke. Advisers identified the need for 
extra training in client-centred consultation skills and 
for additional support to boost confidence. Some phar-
macists felt that NHS remuneration for this activity was 
insufficient. Other pharmacy staff commented that if 
remuneration for pharmacists were increased, they could 
spend more time with smokers, which would result in 
more smokers joining and completing the service. There 
were some practical challenges such as insufficient time 
or resources that meant that advisers did not always seize 
opportunities for engagement and delivery of the service.
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Conversation analysis was conducted on audio 
recordings of 16 pairs of smokers matched on gender, 
ethnicity, age and smoking intensity according to 
whether they were successful or unsuccessful in quit-
ting. Quantitative and qualitative thematic analysis 
of consultation transcripts provided an overview of 
the data that helped us to determine aspects of the 
conversation within the consultation that might be 
associated with quitting or not quitting. Talk about 
the everyday experiences of smokers was common 
and apparently facilitated by a lack of social distance 
between advisers and their clients. This ‘lifeworld’ talk, 
when it was effectively used, enabled advisers to gain 
a better understanding of the smoker’s perspective on 
the quit attempt. In this way advisers could give more 
effective support and facilitate more appropriate strat-
egies to facilitate cessation. Correspondingly, there was 
better alignment in reasons for quitting and relapsing 
between the advisers and smokers who successfully 
stopped smoking compared with those who did not. 
It was apparent from the analysis that patient-centred 
talk was particularly likely to be omitted in deference to 
the ‘voice of medicine’ in non-quitters.25 For example, 
the advisers would give detail about the physiology of 
smoking rather than addressing the social context of 
the smoking behaviour. This form of communication 
led to misalignment of adviser motivational strategies 
with smokers’ reasons for quitting. Thus advisers often 
attempted to motivate clients with talk about financial 
savings, whereas smokers voiced health concerns more 
frequently as reasons for stopping smoking.
Developing a theory base for the initial intervention
Having identified the core issues to address, we reviewed 
which theories would best meet our needs. Specifically 
we matched constructs that we intended to target with 
theories that targeted these constructs, thus ensuring our 
intervention programme theory was underpinned with 
sound behavioural theory and had a clear hypothesised 
mechanism of action. To address capability, we consid-
ered that Social Cognitive Theory26 was relevant to target 
adviseors’ attitudes about benefits of improving smoking 
cessation services both for themselves and the smoker 
(outcome expectancies). This theory was also relevant to 
enhancing adviser’s confidence in engaging clients and 
delivering the smoking cessation service (self-efficacy). 
To address motivation, we considered that Self-Determi-
nation Theory27 with its focus on intrinsic and extrinsic 
motivation would be useful, accounting for personal as 
well as external motivators. For example, financial rewards 
were seen as important to pharmacists running a small 
business. To address opportunity, we set an in-practice 
discussion of how to translate learning into the specific 
pharmacy context as a task to complete before the second 
training session.
Overall, our aim in developing the initial version of 
the intervention was to develop more effective behaviour 
change skills in the smoking cessation advisers and to 
encourage smoker-centred care while avoiding a didactic 
biomedical approach.28
expert advisory group
The group provided advice on each of the key elements 
of the intervention informing and overseeing the devel-
opment process, both shaping the initial intervention 
and making adjustments to create the final version.
InItIAl InterventIOn
Consensus within the expert group suggested that a 
two-session face-to-face training programme targeting 
communication and behaviour change skills with home-
work tasks, social media support and a paper-based 
prompt tool should be the basis for the intervention. 
The social media support took the form of a Facebook 
page that included signposting to resources, links to 
videos on consulting styles and a discussion forum. 
Table 1 shows the content of the intervention with associ-
ated theory and behaviour change techniques.29 Figure 
1 shows the prompt tool developed as an aide memoir 
for use in smoking cessation consultations.
The pilot intervention was delivered jointly by a 
health psychologist (LS) and community pharmacist 
(DA) who was also a trained smoking cessation adviser 
and an NCSCT smoking cessation trainer. We made 
videos with actors demonstrating effective communi-
cation skills and ways of asking questions with scripts 
informed by our audio recordings of real-life consulta-
tions. We used role-plays, demonstration, brainstorming 
and problem-solving as teaching methods throughout 
the training sessions.
Where possible, the behaviour change techniques 
and communication skills in which advisers were being 
trained were modelled within the training sessions 
themselves. For example, advisers’ personal motivations 
for implementing STOP were prompted in the same 
way that we intended them to elicit smokers’ motiva-
tions to stop smoking. The training session on barriers 
and solutions for implementing the intervention used 
open-ended questions to elicit advisers’ own solutions 
rather than simply offering solutions. These techniques 
mirror those that we expected the advisers to use with 
their clients.
PhAse II: PIlOt testIng Of InterventIOn AccePtAbIlIty 
AnD fIDelIty
Piloting delivery of the initial intervention and assess-
ment of fidelity was carried out at the same time as 
piloting the study procedures necessary for the cluster 
randomised trial that will be used to evaluate the final 
version of the intervention. The process of interven-
tion development was iterative so that the theoretical 
modelling and the results from piloting the interven-
tion informed further data collection and analysis.
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Table 1 Actor ratings for assessment of fidelity 
including display of smoking cessation materials, adviser 
communication skills and content of the consultation
Actor 1 Actor 2
Yes No Yes No
NHS Stop Smoking Service 
poster displayed
7 5 9 0
Audio-visual information about 
the NHS Stop Smoking Service
0 12 0 9
Leaflets about the NHS Stop 
Smoking Service
9 3 6 3
Smoking prompts, for 
example, tar jar
4 8 1 8
Were other clients observed 
being asked about smoking?
0 12 0 9
Good body language 6 6 6 3
Good listening skills 3 9 6 3
Use open questions 2 10 3 6
Was topic of smoking raised 0 12 0 9
Was smoking raised directly 1 11 0 9
Was smoking raised indirectly 0 12 0 9
Was client told there is a 
smoking cessation service
6 6 0 9
Was service highlighted as free 
aside from NRT
4 8 0 9
Was it service highlighted as 
delivered by experts
0 12 0 9
Was it highlighted 4× higher 
success rate with programme
2 10 0 9
Asked whether client want 
referral to the service
4 8 0 9
Assess whether client ready to 
change
2 10 0 9
Close by saying door is always 
open
5 7 0 9
NHS, National Health Service; NRT, Nicotine Replacement 
Therapy.
MethODs
Study design
Participants
Any stop smoking advisers working in the London 
boroughs of Tower Hamlets or City and Hackney, and 
in a community pharmacy allocated to the interven-
tion arm of the pilot trial, were eligible to participate 
in the STOP training. All advisers had completed 
NCSCT level 2 training (details of the pilot trial 
have been published previously).30 There were no 
restrictions on time elapsed since training as a stop 
smoking adviser. Advisers could be either pharmacists 
or other pharmacy workers such as counter assistants, 
providing they were trained to deliver stop smoking 
services.
Acceptability of intervention
Attendance
Details on attendance at each training session and any 
reasons given for non-attendance were documented.
Qualitative assessment
All participants who consented to participate in the trial, 
regardless of whether they attended any training sessions, 
were invited to attend a semistructured interview 1 month 
after training. Views about the intervention and practical 
implementation were elicited. We also explored barriers 
and facilitators to attending training sessions and imple-
menting the intervention. The inclusion of individuals 
who did not attend training allowed their perspectives 
on the barriers to attendance to be considered. Inter-
views were conducted by a researcher independent of 
intervention delivery (RS) to minimise risk of social desir-
ability responses. A framework analysis of the data31 was 
conducted by RS.
Intervention fidelity and implementation in practice
We assessed fidelity of the intervention in terms of 
improving smoker engagement by using simulated 
clients, a method previously used for similar assessments 
in community pharmacy.32 Two actors visited each phar-
macy on different days, without prior knowledge of the 
pharmacy, although this had been agreed to at initial study 
consent. The actors presented different clinical scenarios 
designed to give an opportunity for counter staff to 
engage them with the smoking cessation service. A matrix 
was used to ensure that two different case scenarios were 
presented to each pharmacy. Both actors were familiar 
with portraying simulated patients in clinical scenarios in 
Objective Structured Clinical Examinations for medical 
students.
Each actor completed a checklist following the visit 
which included items related to their interaction with 
the adviser, for example, whether a client would like to 
attend the smoking cessation service, general adviser 
communication style and use of study materials such as 
tar jars and stop smoking posters. Both actors underwent 
training before visiting pharmacies and were blind to 
training status.
Self-efficacy
An important hypothesised theoretical mechanism 
for change in adviser behaviour was through increased 
self-efficacy. We assessed this using a validated 0–5 point 
Likert scale, previously used in a similar context33 such 
that higher ratings indicated greater self-efficacy. The 
scale was sent for self-completion 1 month after training 
to all advisers who attended.
results
Intervention acceptability
All 12 stop smoking advisers in the intervention pharma-
cies agreed to participate in the training programme and 
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Figure 1 The Double Whammy paper-based desk prompt. The desk prompt presents key messages from the training in a 
calendar format, displaying examples of how issues may be raised and addressed.
gave informed consent. In total, six advisers completed 
both training sessions (three at the group programme 
and three at a separate in-house training session). One 
participant withdrew after session 1 due to sickness 
and another because of low perceived relevance of the 
training sessions. Four participants did not attend any 
training for reasons detailed below.
In total, 8 of the 12 advisers agreed to interview, 4 of 
whom had attended both training sessions, 1 had attended 
only session 1 and 3 had not attended any training. Six of 
those interviewed were pharmacists, one was a counter 
assistant and one a pharmacy technician (age range 24–52 
years). Five interviewees were male. Themes emerging 
from the analysis of interview transcripts that were related 
to the training are presented in table 1.
Logistics were identified as an important barrier to 
effective use of the training sessions, with participants 
reporting difficulty with both location (at a central training 
site) and timing (in the evenings 19:00 to 21:30). This was 
despite exploratory work that suggested evenings would 
be more convenient. Recommendations for venues closer 
to pharmacies and potential reimbursement to enable 
locum pharmacists to cover for pharmacist absence were 
made. The overall structure and content of the face-to-
face training was acceptable and participants engaged 
well with activities, including role-play.
Only one adviser registered for the Facebook element 
of the intervention. Reasons for not engaging included 
not being allowed to use social media by managers, feeling 
uncomfortable with use of social media and concern related 
to combining social and working lives. Participants reported 
that they felt able to use the newly learnt skills in practice 
and reported using specific techniques, for example, confi-
dence scales, to assist in consultations. Some participants, 
however, felt that it would take time for the new skills to 
become fully embedded in routine practice.
Fidelity assessment
Actor 1 visited all 12 intervention pharmacies, but actor 2 
visited only 9 pharmacies, because of limited availability. 
Table 2 shows ratings for the 18 items of the checklist. 
Actor 2 appeared to rate pharmacies more negatively 
than actor 1 and there was some inconsistency between 
responses for what might be expected to be objective 
items, for example, the presence of a stop smoking 
poster and smoking prompts such as presence of a tar jar. 
Few pharmacy workers with whom the actors came into 
contact had attended the training (approximately 10%) 
as they were counter assistants not specifically trained in 
smoking cessation.
self-efficacy ratings
All 11 advisers completed the pretraining questionnaire 
and 10 completed questionnaires post training. For 
pre training, median score was 4 (range 3.5–4.6) and post 
training 4.5 (4.0–5.0).
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Table 3 Summary of qualitative findings from interviews with smoking cessation advisers related to intervention training
Themes Illustrative quotations
Logistics/organisation of 
training
‘I think it was way out … I've never been there before, and because I close six thirty, … And I can't 
just leave at six thirty on the dot, I've got to tidy up things. So sometimes I don't leave here until 
maybe seven twenty or seven thirty.’
Suggestions to improve the 
logistics of training
‘For us as pharmacists it's difficult because we need to have ourselves covered by another 
pharmacist, otherwise the business can't run. So unless there's compensation for getting a locum 
pharmacists.’
Training structure, content 
including the social media 
support element
‘Yeah it was great … got us involved … It was very informative, the way they actually made us do 
some play-acting to actually show a point to why they were doing that particular part of the talk. 
So that was all good.
to join (facebook) you would have to enrol as a company. So I don't think the boss really wanted 
Facebook as a company ,…’ (Pharmacist)
Reflection on skills learnt ‘So I think this research should carry on for another year, not just six months. Because obviously 
we as practitioners need time … Because it's something new to us as well … There's more 
learning for us to do. It takes time for us to participate and engage.
Like when using the scales, when I try and engage customers I'll ask them on a scale of one to ten 
how ready are you to give up, one being not so ready and ten being very ready. So using those 
trigger questions they're very good, in that little book that we were given.’
Improvement suggestions 
for training structure and 
content
‘I wonder whether there's an ability for the (other pharmacy) staff to be let off work maybe at 
a training session just for staff … or it could be a session where someone from your they can 
maybe …, come in for half an hour and do a similar thing to what we did. But not that in-depth 
that we were trained.’
Application of learnt skills 
in practice and outcomes
‘When you come up to someone, say they came in and then they don't come back for a few 
weeks and then come back again, it's actually to keep the people in. So all the bits we've learnt 
additionally that we found now we've got a better success rate because people are coming back. 
Because we're saying … like sometimes if you talk to someone and you say oh well, you've 
smoked today, you shouldn't have really done that, but now we don't say that. We say look, this is 
a way to try around that, let's see what else we can try to stop you getting into that situation. That 
sort of thing. So we're using different ideas with them.’
PhAse III: InterventIOn refIneMent
Key issues arising from the pilot and fidelity assessments 
that needed to be addressed in revising the STOP inter-
vention were
 ► ensuring that all pharmacy workers in contact with 
smokers were trained in smoker engagement (eg, all 
counter assistants and not just those trained as smok-
ing cessation advisers);
 ► encouraging full attendance at the training sessions 
and display of study materials, financial reward (£30 
cash per participant per session);
 ► understanding organisational barriers to implemen-
tation of the intervention in community pharmacies 
and how these might be overcome.
In response to these issues, we used realist review 
techniques to synthesise previous research on imple-
mentation of complex interventions for smoking 
cessation in community pharmacies, aiming to identify 
factors associated with success or failure of the interven-
tion. The analysis took into account the environment in 
which the intervention was delivered and factors asso-
ciated with the recipient, together with features of the 
intervention itself that might influence effectiveness.34 
We gained insight into how specific interventions 
achieved their outcomes and, where there was an inter-
vention that was only partially effective, the review 
indicated areas where aims had been achieved and the 
reasons why they might not have been achieved. The 
preliminary realist analysis identified four mechanisms 
on which previously reported interventions had been 
operating: pharmacist identity, pharmacist capability, 
pharmacist motivation and stakeholder confidence. 
These mechanisms highlight specific attributes both of 
pharmacists and the wider organisational context that 
could potentially be exploited to enhance the effective-
ness of pharmacy interventions for smoking cessation 
(see online supplementary table S1).35
We selected Diffusion of Innovations Theory (as 
adapted by Greenhalgh et al for the study of organisa-
tional innovation in healthcare)36 to seat the intervention 
within the organisational context of community phar-
macies. This theory can be used to address how new 
methods of service delivery can be embedded and 
sustained in organisations. Amendments to the inter-
vention according to the results of the initial piloting 
and review of theory are illustrated in table 3 in italics. 
An overall description using the TIDieR framework37— 
a tool to facilitate explicit reporting of interventions—is 
presented in online supplementary table S2.
The programme theory giving an overview of the 
intended operation of the intervention represented as 
a logic model38 is shown in figure 2.
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Figure 2 Smoking Treatment Optimisation in Pharmacies programme theory. Logic model of the intended operation of the 
intervention.
DIscussIOn
Statement of principal findings
We developed the STOP intervention in line with current 
Medical Research Council guidance for complex inter-
ventions, incorporating information from previous 
literature and results of our qualitative work with cessation 
advisers. We drew on theories about psychological aspects 
of human behaviour to develop our initial intervention. 
Interviews with pharmacy workers after the pilot study 
suggested that the face-to-face training was well received 
by those attending and that such training might improve 
self-efficacy in delivering smoking cessation interventions. 
However, only 6 of 12 participants attended both training 
sessions and 4 individuals did not attend any sessions, 
suggesting a need for changing recruitment processes.
Our realist review35 suggests that interventions to bring 
about behaviour change in pharmacy workers need to 
take into account role-identity, capability, motivation and 
the wider organisational context in which the interven-
tion is operating. Behaviour change requires practitioner 
practice and continuing support with feedback39 both 
to develop skills and to overcome anxieties about imple-
menting a new form of practice. In the initial intervention, 
this support was anticipated to be available through social 
media, but given that this was not readily accepted, a 
more traditional approach of follow-up sessions within 
practice is proposed for the revised intervention.
Social media is a relatively new phenomenon and 
currently seen as an area of great potential for many 
behavioural interventions;40 however, our study iden-
tifies possible operational barriers that need to be 
considered. For example, healthcare professionals may 
not find it acceptable to blur the boundaries between 
professional and social life. For this form of interven-
tion to be successful, it may be necessary to give greater 
consideration to the motives and barriers towards using 
social media.41 We selected ‘Facebook’ as one of the 
most well-known forms of social media and hence one we 
anticipated participants to be familiar with; however, it is 
possible that different social networking forums may have 
been more acceptable.
Explicit attention needs to be given to the implemen-
tation of the intervention and integration with routine 
practice. Previous systematic reviews in other fields have 
similarly highlighted the importance of implementa-
tion.42 In the revised STOP intervention, we addressed 
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effective implementation using Diffusion of Innovations 
Theory. This theory aims to explain how new ideas spread 
in an organisational system and was useful in identifying 
key items that we needed to include in the intervention; 
for example, allaying concerns before adoption and 
demonstrating that the intervention is not complex and 
fits well with the expanded role of community pharma-
cies. We also highlighted the need for flexibility in how 
the training sessions are delivered, for example, at a 
central location or in individual pharmacies. The revised 
intervention training will be offered at different times of 
day and on different days of the week and those who are 
unable to attend will be offered on-site training.
comparison with other studies
The pilot findings from STOP are in line with previous 
studies that found smoking cessation training acceptable 
to pharmacy workers.9 10 The finding that logistics and 
organisational issues may act as a barrier to implementa-
tion is also in line with evidence that potentially effective 
interventions for smoking cessation advisers have been 
developed but may not have changed quit rates or uptake 
of smoking cessation services.43 The explicit application 
of organisational theory in development of the STOP 
intervention is an attempt to address this problem.
A realist review by our own team, undertaken in 
parallel with the fieldwork on this complex intervention 
and feeding into its final refinement, confirmed two key 
aspects of our empirical findings. First, that training in 
both factual knowledge and skills to enhance self-efficacy, 
informed by theories of behaviour change, improves the 
capacity and confidence (capability and motivation) of 
front-line pharmacy staff in supporting smoking cessation. 
Second, that organisational barriers (opportunity) may 
be significant even when individual motivation and capa-
bility are targeted. An additional finding from the realist 
analysis of the literature suggests that uptake and sustain-
ability of pharmacy-based smoking cessation support 
depends on public and professional trust in the extended 
role of the pharmacist, which in turn depends on posi-
tive messages from the media and professional bodies. In 
the revised intervention, we recommend support from 
local champions such as Healthy Living Leads, which may 
partly address this issue.
strengths and weaknesses
A strength of the current study was the development work 
prior to piloting the intervention and using a recom-
mended behavioural intervention development system to 
guide this.19 We conducted qualitative work in community 
pharmacies, which helped us to gain an understanding 
of the detailed interactions between cessation advisers 
and their clients and used this to develop and refine the 
intervention. We concurrently developed a theoretical 
framework to underpin the intervention, drawing both 
from psychological theories related to behaviour change 
and organisational theory attempting to explain how 
interventions become incorporated into routine practice. 
Having established a framework, we translated this into 
behaviour change techniques to facilitate change in our 
three target behaviours: (1) increased engagement of 
smokers, (2) retaining individuals in the stop smoking 
service and (3) improving quit rates. Our work builds 
on the behaviour change techniques thought to be most 
effective for smoking cessation16 but which may not be 
well implemented in routine practice.43
It is a further strength of the current study that we 
addressed organisational aspects likely to influence the 
effectiveness of the interventions. Studies developing 
smoking cessation interventions to date have mainly 
focused on theories of individual behaviour change such 
as the transtheoretical model.44While studies designed 
to test this approach show some benefit,45 such theories 
tend not to take into account broader considerations of 
how the intervention might be implemented. We are not 
aware of previous programmes in community pharmacies 
that have explicitly used organisational theory in addi-
tion to psychological theory to develop an intervention. 
Although some previous studies have compared different 
models of service delivery, these have not provided a 
theory-based exploration of the mechanisms by which 
the intervention brought about behaviour change in 
different settings.46 47 As a result, it is difficult to generalise 
from these trials because mechanisms may be operating 
differently in different community pharmacies.48 A 
consideration of theoretical perspectives on the imple-
mentation of interventions to supplement psychological 
theories of behaviour change would seem prerequisite if 
the intervention is to work reliably in diverse settings.
Our assessment of intervention fidelity is also a 
strength.43 In this study, we used simulated clients to 
assess the degree to which core elements of the inter-
vention were reflected in engagement behaviour of 
pharmacy staff. These methods have previously been used 
successfully in community pharmacies.32 49 50 The simu-
lated client methodology was informative in identifying 
areas where the intervention needed increased focus, 
for example, the need to extend training to all commu-
nity pharmacy workers. While the simulated client visits 
provided a qualitative assessment of intervention fidelity 
and engagement behaviour, it was a weakness that there 
was no quantitative assessment due to the small scale of 
the pilot study. In addition, we found some discrepancy 
between actors in scoring apparently objective measures 
such as presence or absence of stop smoking posters. This 
raises questions over the reliability of this method and the 
need for increased training of actors to ensure any assess-
ment is robust.
A weakness of the study was that both our preinterven-
tion development (qualitative studies) and piloting drew 
on the experience of pharmacies which were sufficiently 
engaged in the topic area to participate in a research 
study. There may be additional barriers to implementa-
tion for pharmacies that do not see smoking cessation as 
a priority. In addition, there may be practical problems 
such as lack of a private consulting room, which could 
group.bmj.com on August 29, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 11Steed L, et al. BMJ Open 2017;7:e015637. doi:10.1136/bmjopen-2016-015637
Open Access
make implementation difficult in some pharmacies. The 
recent development of the Healthy Living Pharmacy 
framework2 will mean that pharmacies are increasingly 
better equipped for smoking cessation and other health 
behaviour change tasks. It is therefore timely for phar-
macy workers to be suitably trained in behaviour change 
skills.
A limitation of the qualitative data from the adviser 
interviews was that advisers’ self-report of their experi-
ence of attending training sessions may be subject to 
social desirability responses. Nevertheless, the fact that 
a researcher independent from the intervention team 
conducted the interviews adds some validity to this assess-
ment.
Implications for clinical practice and policymakers
We found that smoking cessation advisers were gener-
ally motivated to support their clients to change health 
behaviours and were receptive to additional skills training. 
However, we identified a gap in referral of smokers from 
non-smoking cessation-trained counter assistants to 
trained smoking cessation advisers. This suggests that in 
order to engage smokers more effectively a wider work 
force than stop smoking advisers needs to be trained. 
Nevertheless, the results from our pilot studies provide 
initial evidence that STOP may be an acceptable and 
potentially effective intervention.30
Implications for future research
While many health systems are expanding the role of 
community pharmacies into lifestyle management, 
there has been very little research on the effectiveness 
of pharmacy workers in their extended roles.51 Since 
there are substantial economic implications for funding 
wider delivery of primary healthcare through pharma-
cies, health commissioners may need stronger evidence 
before decisions on allocation of funding are made. Such 
evidence will require large-scale studies to evaluate the 
effectiveness and cost effectiveness of changes in service 
delivery and further investigation into the organisational 
barriers to implementation.
ADDItIOnAl InfOrMAtIOn
The training and intervention materials, including the 
intervention manual, will be available on request from 
the authors following completion of the evaluation phase 
of the STOP programme.
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